Company / Operating Income
DNA X, Inc. Operating Income History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$513.0K
FY2024
5-year range
-$38.0M / $513.0K
FY2020-FY2024
Trend
+103.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$38M to $513,000 over the past 2 years.
Based on SEC 10-K filings.
$513,000 in FY2024 with a 5-year CAGR of -37.5%.
Improved from -$38M to $513,000 over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -37.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -37.5%, indicating a declining trend.
- In FY2024, operating income increased 103.6% year-over-year.
- Peak operating income was recorded in FY2019.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $513.0K | +103.6% |
| FY2023 | -$14.3M | +62.4% |
| FY2022 | -$38.0M | -29.9% |
| FY2021 | -$29.3M | -30.7% |
| FY2020 | -$22.4M | -514.9% |
| FY2019 | $5.4M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026